Nephros Inc (NEPH) stock
NEPHNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3020% below fair value
$2.90−0.10 (-3.33%)
Close on Nov 17, 2026Market cap $31.49MP/E 18.1Yield –
Nephros pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
Nephros's pe ratio was 19.2× on Nov 11, 2026, against 37.5× a year earlier. Over the last 3 years it ranged from 0.2× to 200.0×, with a median of 26.8×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 19.2× | −18.3 |
| 2025 | Dec 31, 2025 | 37.5× | +28.1 |
| 2014 | Apr 30, 2014 | 9.4× | +6.9 |
| 2012 | Jan 31, 2012 | 2.6× | +0.6 |
| 2011 | Dec 30, 2011 | 2.0× | – |
See a number that looks wrong?